Agentic AI in oncology distills evidence, molecular data, and guidelines to aid therapy decisions, promising smarter, context ...
Although he typically prefers to minimize time spent in the hospital and has an hour-long commute to the academic center, he understands that CAR T-cell therapy requires treatment at a specialized ...
The FDA has granted breakthrough therapy designation and fast track designation to 68Ga-NYM096, an investigational PET ...
The FDA has granted fast track designation to safusidenib, an oral IDH1 inhibitor, based on durable phase 2 J201 study ...
David Savage, MD, PhD, discusses the greater significance of the PFS benefit observed in a trial of darovasertib plus ...
FDA fast track status supports accelerated development of PLN-101095 plus pembrolizumab for ICI-refractory solid tumors, ...
The Journal of Targeted Therapies in Cancer | Targeted Publications | Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results